Zai Lab of Shanghai Plans $150 Million IPO in the US

Life Science

Fosun and Shanghai Pharmas Competing for $700 Million Stake in US-based Arbor

Life Science

Hong Kong Test Shows Efficacy of Early Cancer Liquid Biopsy Testing

Life Science

Biocept Raises $2.2 Million from Ally Bridge; Plans China Expansion

Life Science

New Horizon Raises $20 Million for Diagnostics in Qiming-Led B Round

Life Science

Shenzhen Salubris May Acquire Liver Cancer Candidate from US NIH

Life Science

Gold could be used in cancer treatment, researchers say

Life Science

Shanghai Pharma Negotiating with DHL on Global Drug Distribution

Life Science

Hangzhou Just Bio Raises $57 Million for Biologic Drug Development

Life Science

Korea’s ViroMed Starts Trial of Gene Therapy for Diabetic Foot Ulcers

Life Science

GSK To Close Shanghai Neurological R&D Operations

Life Science

Bayer Offers Concessions to EU Commission for Monsanto Deal

Life Science, Others

Chi-Med’s Innovative Drug Portfolio: Eight Candidates in 31 Trials

Life Science

UCL-developed stem therapy culled from Pfizer’s pipeline

Life Science

Will Fosun’s deal go ahead amid the Sino-Indian spat?

Life Science